BCL7B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.082600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.312200E-01
Normal-vs-Stage2
6.443800E-01
Normal-vs-Stage3
4.252000E-01
Normal-vs-Stage4
6.025000E-01
Stage1-vs-Stage2
3.329200E-01
Stage1-vs-Stage3
1.561770E-01
Stage1-vs-Stage4
3.181800E-01
Stage2-vs-Stage3
7.827700E-02
Stage2-vs-Stage4
8.855800E-01
Stage3-vs-Stage4
2.555400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.199200E-01
Normal-vs-AfricanAmerican
6.113200E-01
Normal-vs-Asian
6.139000E-01
Caucasian-vs-AfricanAmerican
9.662000E-01
Caucasian-vs-Asian
9.305200E-01
AfricanAmerican-vs-Asian
9.825400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.558600E-01
Normal-vs-Female
6.945800E-01
Male-vs-Female
4.786400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.025800E-01
Normal-vs-Age(41-60Yrs)
2.108400E-01
Normal-vs-Age(61-80Yrs)
8.283800E-01
Normal-vs-Age(81-100Yrs)
5.359200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.390600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.319000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.578000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.322300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.851010E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.289400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.899000E-01
Normal-vs-Daily Drinker
4.202600E-01
Normal-vs-Weekly Drinker
6.158000E-01
Normal-vs-Occasional Drinker
4.911200E-01
Normal-vs-Social Drinker
3.583200E-01
Non Drinker-vs-Daily Drinker
2.309800E-02
Non Drinker-vs-Weekly Drinker
1.217370E-01
Non Drinker-vs-Occasional Drinker
6.395600E-02
Non Drinker-vs-Social Drinker
1.445910E-02
Daily Drinker-vs-Weekly Drinker
8.110000E-01
Daily Drinker-vs-Occasional Drinker
6.994000E-01
Daily Drinker-vs-Social Drinker
5.881200E-01
Weekly Drinker-vs-Occasional Drinker
9.482400E-01
Weekly Drinker-vs-Social Drinker
5.354200E-01
Occasional Drinker-vs-Social Drinker
3.926400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.158600E-01
Normal-vs-Grade 2
5.260000E-01
Normal-vs-Grade 3
8.765900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.029200E-01
Grade 1-vs-Grade 3
7.378600E-01
Grade 1-vs-Grade 4
2.158600E-01
Grade 2-vs-Grade 3
7.883600E-01
Grade 2-vs-Grade 4
5.260000E-01
Grade 3-vs-Grade 4
8.765900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.914000E-01
Normal-vs-NonDiabetic
4.947400E-01
Diabetic-vs-NonDiabetic
1.112020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.071780E-01
Normal-vs-NoPancreatitis
6.670200E-01
Pancreatitis-vs-NoPancreatitis
6.360500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.791600E-01
Normal-vs-N1
7.003600E-01
N0-vs-N1
4.406000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.821200E-01
Normal-vs-TP53-NonMutant
1.643170E-01
TP53-Mutant-vs-TP53-NonMutant
6.550800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
